<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00163813</url>
  </required_header>
  <id_info>
    <org_study_id>232/04</org_study_id>
    <nct_id>NCT00163813</nct_id>
  </id_info>
  <brief_title>The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care (ENTERIC) Study</brief_title>
  <acronym>ENTERIC</acronym>
  <official_title>The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayside Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bayside Health</source>
  <brief_summary>
    <textblock>
      This is a multi-centre randomised controlled trial comparing early jejunal feeding (using a&#xD;
      frictional nasojejunal [NJ] tube) and standard feeding in critical illness.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The amount of EN delivered during the Intensive Care Unit (ICU) stay</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Amount of EN delivered during the first 10 days of the study</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily cumulative proportion of EN delivered</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator-associated pneumonia rate</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalisation</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality at hospital discharge</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success rate of placement into both the small bowel, generally, and the jejunum, specifically</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication rates (as compared to the nasogastric tube)</measure>
  </secondary_outcome>
  <enrollment>180</enrollment>
  <condition>Critical Illness</condition>
  <condition>Malabsorption Syndromes</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Early jejunal feeding (using frictional NJ tube)</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard feeding (using nasogastric [NG] tube)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        ICU patients are eligible for enrolment if they meet all of the following:&#xD;
&#xD;
          -  Age &gt; 18 years old&#xD;
&#xD;
          -  In ICU for &lt; 48 hours prior to enrolment&#xD;
&#xD;
          -  Receiving invasive mechanical ventilation (through an endotracheal tube or&#xD;
             tracheostomy, but NOT a facemask) with an anticipated need for &gt; 48 hours of&#xD;
             mechanical ventilation&#xD;
&#xD;
          -  Receiving a continuous infusion of any one of:&#xD;
&#xD;
               -  morphine &gt; 2 mg/hour,&#xD;
&#xD;
               -  fentanyl &gt; 20 mcg/hour, or&#xD;
&#xD;
               -  pethidine &gt; 20 mg/hour&#xD;
&#xD;
          -  Either a single GRV &gt; 150 mls (whilst receiving EN via a NG tube) or nasogastric&#xD;
             drainage &gt; 500 mls over 12 hours (whether receiving EN or not)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients will be ineligible for enrolment if they meet any of the following:&#xD;
&#xD;
          -  Previous or recent surgery which has altered the anatomy of the upper gastrointestinal&#xD;
             tract (eg. oesophagectomy, gastrectomy, any gastric anastomosis surgery, gastroplasty,&#xD;
             pyloroplasty, pancreaticoduodenectomy [Whipple's procedure])&#xD;
&#xD;
          -  Known gastric malignancy&#xD;
&#xD;
          -  Known oesophageal varices&#xD;
&#xD;
          -  Current admission for peptic ulceration&#xD;
&#xD;
          -  Current mechanical bowel obstruction&#xD;
&#xD;
          -  Current gastrostomy, jejunostomy, or surgically-placed enteral tube in situ&#xD;
&#xD;
          -  Contraindication to the use of the nose and mouth for enteral tube insertion (eg.&#xD;
             recent facial trauma or surgery)&#xD;
&#xD;
          -  Receiving nutritional support prior to ICU admission&#xD;
&#xD;
          -  Severe coagulopathy (defined by platelet count &lt; 20 and/or international normalized&#xD;
             ratio [INR] &gt; 4.0)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew Davies</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Alfred</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrew Davies</last_name>
    <phone>+61 3 92762607</phone>
    <email>a.davies@alfred.org.au</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Siouxzy Morrison</last_name>
    <phone>92071343</phone>
    <email>s.morrison@alfred.org.au</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3181</zip>
        <country>Australia</country>
      </address>
    </facility>
    <contact>
      <last_name>Siouxzy Morrison</last_name>
      <phone>92071343</phone>
      <email>s.morrison@alfred.org.au</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>August 2005</verification_date>
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2005</study_first_posted>
  <last_update_submitted>February 23, 2007</last_update_submitted>
  <last_update_submitted_qc>February 23, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 26, 2007</last_update_posted>
  <keyword>Mechanically-ventilated</keyword>
  <keyword>medical-surgical critically ill patients</keyword>
  <keyword>reduced gastric motility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malabsorption Syndromes</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

